- Home
- HEPS vs OCS Comparison
HEPS vs OCS Comparison
Compare HEPS & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPS
- OCS
- Stock Information
- Founded
- HEPS 2000
- OCS 2003
- Country
- HEPS Turkey
- OCS Switzerland
- Employees
- HEPS N/A
- OCS N/A
- Industry
- HEPS Catalog/Specialty Distribution
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- HEPS Consumer Discretionary
- OCS Health Care
- Exchange
- HEPS Nasdaq
- OCS Nasdaq
- Market Cap
- HEPS 909.5M
- OCS 956.4M
- IPO Year
- HEPS 2021
- OCS N/A
- Fundamental
- Price
- HEPS $2.96
- OCS $17.90
- Analyst Decision
- HEPS
- OCS Strong Buy
- Analyst Count
- HEPS 0
- OCS 3
- Target Price
- HEPS N/A
- OCS $35.33
- AVG Volume (30 Days)
- HEPS 617.2K
- OCS 10.9K
- Earning Date
- HEPS 07-30-2025
- OCS 08-21-2025
- Dividend Yield
- HEPS N/A
- OCS N/A
- EPS Growth
- HEPS N/A
- OCS N/A
- EPS
- HEPS N/A
- OCS N/A
- Revenue
- HEPS $1,477,672,859.00
- OCS $847,333.00
- Revenue This Year
- HEPS $33.20
- OCS $11.49
- Revenue Next Year
- HEPS $25.66
- OCS $1,784.02
- P/E Ratio
- HEPS N/A
- OCS N/A
- Revenue Growth
- HEPS 49.45
- OCS N/A
- 52 Week Low
- HEPS $2.11
- OCS $10.79
- 52 Week High
- HEPS $4.05
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- HEPS 62.94
- OCS 45.94
- Support Level
- HEPS $2.61
- OCS $17.70
- Resistance Level
- HEPS $3.09
- OCS $18.57
- Average True Range (ATR)
- HEPS 0.14
- OCS 0.41
- MACD
- HEPS 0.04
- OCS 0.04
- Stochastic Oscillator
- HEPS 80.60
- OCS 48.46
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.